Follow
Clinical Trial Testing
Clinical Trials are medical research involving human subjects. Clinical Trials evaluate medical, surgical, or behavioral interventions to determine if a novel treatment is safe and effective. There are four phases of Clinical Trial testing used to test the new treatment, determine the most effective dosage, and ensure the adverse effects do not outweigh the medical benefits.
NOV 16, 2023 | 10:00 AM
Across various stages of the clinical oncology workflow, from panel design to genomic testing and molecular tumor boards, the identification and validation of actionable genomic alterations...
NOV 14, 2023 | 6:00 AM
C.E. CREDITS
It is over half a century since haemoglobin A1c (HbA1c) was recognised by medical professionals; the importance of HbA1c to the long term health of people with diabetes was clearly demonstra...
NOV 01, 2023 | 8:00 AM
To bring your cutting-edge cell and gene therapies to the patients that need them as quickly as possible, you need access to the most knowledgeable scientists, innovative technologies, metho...
OCT 24, 2023 | 8:00 AM
To bring your cutting-edge cell and gene therapies to the patients that need them as quickly as possible, you need access to the most knowledgeable scientists, innovative technologies, metho...
OCT 10, 2023 | 10:00 AM
C.E. CREDITS
For patients with advanced non-small cell lung cancer (NSCLC), tissue samples are typically small biopsies. These samples undergo standard of care evaluation for >10 biomarkers to identif...
OCT 10, 2023 | 9:00 AM
Numerous studies have shown that homologous recombination deficiency (HRD) is a genome-wide biomarker present in high grade ovarian and breast cancers. A cancer therapeutic class, PARP inhib...
OCT 10, 2023 | 1:00 AM
Numerous studies have shown that homologous recombination deficiency (HRD) is a genome-wide biomarker present in high grade ovarian and breast cancers. A cancer therapeutic class, PARP inhib...
AUG 10, 2023 | 8:00 AM
C.E. CREDITS
Antibody therapeutics is a fast-growing market boosted by developments in bispecific antibodies and in newly emerging tetra-specific antibodies. With the ability to recruit a combination of...
MAY 16, 2023 | 8:00 AM
The therapeutic use of chimeric antigen receptor T cells has achieved significant success in the treatment of B cells malignancies. Despite promising results in mouse tumor models, a similar...
MAR 23, 2023 | 8:00 AM
Date: March 23, 2023 Time: 8:00am (PDT), 11:00am (EDT), 8:00pm (CEST) Across clinical oncology applications, from molecular testing to cancer research the ability to identify potentially act...
FEB 22, 2023 | 5:30 AM
C.E. CREDITS
Ninety percent of therapeutic agents reaching clinical trial fail to reach entry to market, with safety concerns being a major cause for failures in phase I and II clinical trials. Drug-indu...
FEB 21, 2023 | 10:00 AM
C.E. CREDITS
Date: February 21, 2023 Time: 10:00am (PST), 1:00pm (EST), 7:00pm (CET) The use of algorithms that alter patient medical care based on race has fallen under increasing criticism, as race-bas...
NOV 09, 2022 | 8:00 AM
Date: November 09, 2022 Time: 8:00am (PST), 11:00am (EST), 5:00pm (CET) The field of cell and gene therapy is rapidly growing. In particular, the use of lentiviruses in CAR-T applications is...
OCT 19, 2022 | 1:30 PM
COVID-19 remains a global health emergency with limited treatment options, lagging vaccine rates, and inadequate healthcare resources in the face of an ongoing calamity. The disease is chara...
AUG 16, 2022 | 7:00 AM
Date: August 16, 2022 Time: 7:00am (PDT), 10:00am (EDT), 4:00pm (CEST) In this session, researchers, clinicians, and program implementers from four countries will address the disruption in co...
JUN 21, 2022 | 6:00 AM
Date: June 21, 2022 Time: 6:00am (PDT), 9:00am (EDT), 3:00pm (CEST) The global understanding and practice of medicine is currently undergoing a revolutionary change. This shift to precision...
APR 21, 2022 | 5:30 AM
A hypoxic tumour microenvironment is a feature of solid tumours. Many tumour types contain high fractions of hypoxic tissue. The relationship between high levels of tumour hypoxia and a poor...
APR 20, 2022 | 5:30 AM
Esophageal adenocarcinoma [EAC] is the fastest growing in incidence cancer in the US over the last 25 years, while also having a 5 year survival of less than 20%. Barrett’s Esophagus [...
APR 14, 2022 | 8:00 AM
Date: April 14, 2022 Time: 8:00am (PDT), 11:00am (EDT), 5:00pm (CET) Across oncology applications, from research to molecular testing and pharmaceutical development, the ability to identify...
MAR 23, 2022 | 11:55 PM
In-house testing is not required federally; however, states differ in their requirements. Cannabis extraction laboratories need to test extracts for pesticides, heavy metals, residual solven...
MAR 16, 2022 | 7:00 AM
Date: March 16, 2022 Time: 07:00am (PDT), 10:00am (EDT), 4:00pm (CEDT) During this webinar, we will provide an overview of the current landscape of sepsis management and the impact of rapid...
FEB 24, 2022 | 8:00 AM
Date: February 24, 2022 Time: 08:00am (PST), 11:00am (EST) Fume hoods are often the largest consumers of energy in a lab space and are consequent...
AUG 16, 2022 | 7:00 AM
Date: August 16, 2022 Time: 7:00am (PDT), 10:00am (EDT), 4:00pm (CEST) In this session, researchers, clinicians, and program implementers from four countries will address the disruption in co...
JUN 21, 2022 | 6:00 AM
Date: June 21, 2022 Time: 6:00am (PDT), 9:00am (EDT), 3:00pm (CEST) The global understanding and practice of medicine is currently undergoing a revolutionary change. This shift to precision...
APR 21, 2022 | 5:30 AM
A hypoxic tumour microenvironment is a feature of solid tumours. Many tumour types contain high fractions of hypoxic tissue. The relationship between high levels of tumour hypoxia and a poor...